Davis’s Drug Guide for nurses 16th edition PDF Free

The Davis Nurses’ Medication Guide provides comprehensive and up-to-date information on medications in well-organized, nursing-focused monographs. It also includes extensive supplemental material in 16 appendices, addresses the topic of safe medication administration in detail, and educates the reader on 50 different therapeutic classes of medications. In this 16th edition, we’ve continued the tradition of focusing on safe medication administration by including medication safety tools and even more information on the most vulnerable patients in healthcare: children, the elderly, and pregnant and lactating women. Look for more Pedi, Geri, OB, and Lactation headings throughout the monographs. In addition, we have included relevant information for Canadian students and nurses. You’ll find an appendix comparing Canadian and US pharmaceutical practices, plus Canadian-only combination drugs in the Combination Drugs appendix, and other Canadian brand names in the drug monographs. You can download Davis’s Drug Guide for nurses 16th edition PDF Free

Articles on the safe use of medicines “Medication Errors: Improving Practices and Patient Safety”, “Detection and Management of Adverse Drug Reactions”, “Overview of Risk Evaluation and Mitigation Systems (REMS)”, “Special Dosage Considerations” and “Educating Patients About Safe Medications.” Usage” covers articles on the safe use of medications and provides an overview of medication safety issues facing physicians and patients. As you begin this series, the medication errors article familiarizes you with the systems problems and clinical situations repeatedly implicated in medication errors and suggests practical ways to avoid them. It also teaches you about high-alert medications, which have a greater potential to cause patient harm than other medications. “Detecting and Managing Adverse Drug Reactions” explains the different types of adverse reactions and provides guidance on how to detect and manage them. “Risk Evaluation and Mitigation Strategies (REMS)” explains strategies developed by the pharmaceutical industry and mandated by the Food and Drug Administration (FDA) to minimize adverse drug reactions from potentially dangerous drugs. We have highlighted drugs that currently have approved REMS programs associated with their use by adding a REMS label to the top of the corresponding drug monographs.

“Special Dosing Considerations” identifies patient populations, such as neonates and patients with renal insufficiency, that require careful dosage adjustments to ensure optimal therapeutic results. “Educating Patients About Medication Use” reviews the most important teaching points for nurses to discuss with their patients and their families. In addition to these safety articles, other critical information is highlighted in red throughout the drug monographs. This allows the reader to quickly identify important information and see how nursing practice, including assessment, implementation, and patient education, relates to it.

Drug Monographs

The drug monographs are organized as follows: High Alert Status – Some drugs, such as chemotherapy agents, anticoagulants, and insulins, have a greater potential for harm than others. These medications have been identified by the Institute for Safe Medication Practices as high alert medications. The Davis Nurses Medication Guide includes a high alert tab in the upper right-hand corner of the monograph header under appropriate medications to alert the nurse to the risk of the medication. The term “high alert” is also used elsewhere in the monograph to help the nurse administer these medications safely. See the article “Medication Errors: Improving Practices and Patient Safety” for a complete list of high-alert medications in the Davis Nurses’ Medication Guide. See ISMP.org for all individual high alert solutions, groups, and medications. Generic/Brand Name: The generic name appears first, with a pronunciation key, followed by an alphabetical list of trade names. Canadian trade names are preceded by a maple leaf.

Brand names that have been discontinued have a slash through them (Decadron). Common names, abbreviations, and selected foreign names are also included. Classification: The therapeutic classification appears first, which categorizes drugs according to the disease state for which they are used, followed by the pharmacological classification, which is based on the drug’s mechanism of action. Controlled Substances List: All drugs regulated by federal law are placed on one of five schedules, based on the drug’s medicinal value, harmfulness, and potential for abuse or addiction. Schedule I drugs, the most dangerous and of no medicinal value, are not included in the Davis Nurses’ Drug Guide. (See Appendix I for a description of the Controlled Substances List.) Pregnancy Category: The FDA recently recommended discontinuation of the pregnancy category system (A, B, C, D, and X) as this categorization may not adequately communicate the risk a drug may have during pregnancy or lactation. Based on this guidance, the pregnancy categories have been removed from each of the drug monographs. These pregnancy letter categories have been replaced in drug prescribing information with a narrative summary that describes the potential risk of using the drug during pregnancy and lactation, as well as in women and men of reproductive age. Drug monographs have been enhanced with this detailed information on these patient populations. Indications: Medications are approved by the FDA for specific diseases. This section identifies diseases or conditions for which the drug is commonly used and also includes significant off-label uses. Action: This section contains a concise description of how the drug produces the desired therapeutic effect. Pharmacokinetics: Pharmacokinetics refers to how the body processes a drug by absorption, distribution, metabolism, and excretion. This section also includes information about the drug’s half-life.

Phillips LD, Gorski LA. Manual of I.V. Therapeutics. 6th Edition. F.A. Davis Company: Philadelphia,
2014.

Topics of 16th Edition

• Contents
• How to Use Davis’s Drug Guide for Nurses
• Evidence-Based Practice and Pharmacotherapeutics: Implications for Nurses
• Pharmacogenomics
• Medication Errors: Improving Practices and Patient Safety
• Detecting and Managing Adverse Drug Reactions
• Overview of Risk Evaluation and Mitigation Systems (REMS)
• Special Dosing Considerations
• The Cytochrome P450 System: What Is it and Why Should I Care?
• Educating Patients about Safe Medication Use
• Classifications
• Drug Monographs in Alphabetical Order by Generic Name
• Drugs Approved in Canada
• Natural/Herbal Products
• Medication Safety Tools

Educating patients about safe medication use

Research has shown that patients need information on various drug-related topics, no matter what the drug is. A well-informed patient and/or family can help prevent medication errors by hospital staff and are less likely to make medication errors at home. Adherence to the medication regimen is another goal achieved through patient education. However, before beginning any teaching, always assess the patient’s current knowledge by asking if they are familiar with the medication, how it is taken at home, what precautions or follow-up care are required, and other medication-specific questions. Based on the patient’s current level of knowledge and taking into account factors such as readiness to learn, environmental and social barriers to learning or adherence, and cultural factors. Read more on the page No.30

About the Author

April Hazard Vallerand Ph. D., RN, FAAN, Alumni Endowed Professor at Wayne State University School of Nursing, has focused her research on understanding factors that affect functional status and barriers to improving pain management in patients with pain in a variety of settings.

 

Davis’s Drug Guide for nurses 17th Edition is here

Description:

 

 

 

 

If downloading does not start then use Download link 2

 

 

Download Link 2